鼓室注射辅助全身应用糖皮质激素联合高压氧治疗突发性耳聋的疗效
作者: |
1陈菲,
1朱艳香,
1刘文彬,
2宋广朴,
3谢微
1 廊坊市第四人民医院 耳鼻喉科,河北 廊坊 065700 2 廊坊市第四人民医院 中医内科,河北 廊坊 065700 3 廊坊市第四人民医院 消化科,河北 廊坊 065700 |
通讯: |
朱艳香
Email: zyx197203@163.com |
DOI: | 10.3978/j.issn.2095-6959.2019.10.013 |
基金: | 廊坊市科学技术研究与发展计划 (2018013043)。 |
摘要
目的:探讨鼓室注射辅助全身应用糖皮质激素联合高压氧治疗突发性耳聋的疗效及其对患者炎症和应激反应状态的影响。方法:选取2015年6月至2018年11月在廊坊市第四人民医院耳鼻咽喉科诊治的突发性耳聋(sudden deafness,SD)患者128例,随机分为A组(n=64)和B组(n=64)。A组实施糖皮质激素全身给药联合高压氧治疗,B组在A组治疗基础上加用糖皮质激素鼓室注射治疗。比较两组治疗后平均纯音听阈、疗效、血浆C-反应蛋白(C-reactive protein,CRP)、一氧化氮(nitric ox ide,NO)水平及一氧化氮合成限速酶一氧化氮合酶(nitric ox ide synthase,NOS)活性。记录两组治疗期间不良反应及并发症。结果:1)与治疗前比较,两组治疗后平均纯音听阈均明显下降(P<0.05),但B组下降幅度及听阈增益均高于A组;2)两组中度以下SD总体有效率及总体显效率差异无统计学意义(P>0.05),但B组重度以上SD总体有效率及总体显效率均高于A组(P<0.05);3)两组治疗前CRP,NO水平和NOS活性差异无统计学意义(P>0.05),与治疗前比较,两组治疗后CRP水平下降、NO水平和NOS活性升高(P均<0.05),但B组变化程度大于A组(P<0.05);4)两组均未发生严重不良反应及并发症。结论:鼓室注射辅助全身应用糖皮质激素联合高压氧治疗重度以上SD的疗效较好,有助于减轻患者的炎症和应激反应状态,可能是其治疗有效性的重要作用机制。
关键词:
鼓室注射;全身应用;糖皮质激素;高压氧;突发性耳聋
Clinical effects of systemic administration assisted with intratympanic injection of glucocorticoid combined with hyperbaric oxygen on sudden deafness
CorrespondingAuthor: ZHU Yanxiang Email: zyx197203@163.com
DOI: 10.3978/j.issn.2095-6959.2019.10.013
Foundation: This work was supported by Langfang Science and Technology Research and Development Plan, China (2018013043).
Abstract
Objective: To observe the clinical effects of systemic administration assisted with intratympanic injection of glucocorticoid combined with hyperbaric oxygen on sudden deafness (SD) and its influences on inflammation and stress response of the patients. Methods: From June 2015 to November 2018, 128 patients with SD at the Otolaryngology Department of the Fourth People’s Hospital of Langfang City were included in this study, all patients were randomly divided into group A (n=64) and group B (n=64). Group A was treated with systemic glucocorticoid administration combined with hyperbaric oxygen, and group B was treated with glucocorticoid tympanic injection on the basis of group A. After treatment, the mean pure tone threshold, curative effect, plasma C-reactive protein (CRP), nitric oxide (NO) level and nitric oxide synthesis rate-limiting enzyme nitric oxide synthase (NOS) activity were compared between the two groups. The adverse reactions and complications were recorded in the two groups. Results: 1) Compared with those before treatment, the mean pure tone auditory threshold decreased significantly after treatment in both groups (P<0.05), but the decreasing amplitude and auditory threshold gain in group B were higher than that in group A (P<0.05); 2) there were no statistically significant differences between the two groups in overall efficiency and significant efficiency of SD below moderate level (P>0.05), but the overall efficiency and significant efficiency of SD above severe level in group B were higher than those in group A (P<0.05); 3) there were no statistical differences in CRP and NO levels and NOS activity before treatment between the two groups (P>0.05). CRP level decreased, NO level and NOS activity increased after treatment between the two groups (P<0.05), but the change degree of group B was greater than those of group A (P<0.05); 4) no serious adverse reactions and complications occurred in both groups. Conclusion: Intratympanic injection assisted with systemic administration of glucocorticoid combined with hyperbaric oxygen can yield better results in SD above severe level, which may be attributed to reduced inflammation and stress response.
Keywords:
intratympanic injection; systemic application; glucocorticoids; hyperbaric oxygen; sudden deafness